Physician profile
Emma B Armistead
NPI 1164165197
$271.36
in general payments reported to CMS, 2019-2025
8 companies · $66.52 in 2025
The $66.52 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.43 · 2023: $104 · 2024: $80.27 · 2025: $66.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $66.83 | 2023-2025 | |
| Novo Nordisk INC | $63.08 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Idorsia Pharmaceuticals US INC | $54.04 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $23.26 | 2024 | Cologuard Collection Kit |
| Viiv Healthcare Company | $17.74 | 2024 | Apretude |
| Glaxosmithkline, LLC. | $16.03 | 2025 | Trelegy Ellipta |
| Supernus Pharmaceuticals, INC. | $15.47 | 2023 | Qelbree |
| Lilly USA, LLC | $14.91 | 2025 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Armistead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.